More Evidence TNF Inhibitors Raise Risk of Peripheral Neuropathy

NEW YORK (Reuters Health)—A large epidemiological study provides more evidence of a link between tumor necrosis factor inhibitors (TNFi) and peripheral neuropathy (PN). “These events are rare and the benefit of these drugs still outweigh this risk so this should not change practice,” cautions first author Dr. Mahyar Etminan from the University of British Columbia... [Read More]

Source: The Rheumatologist - October 8, 2018 Category: Rheumatology Authors: Megan Brooks Tags: DMARDs & Immunosuppressives Drug Updates Peripheral Neuropathy TNF inhibitors tumor necrosis factor tumor necrosis factor (TNF) inhibitors Source Type: research